Product
epoetin alfa
1 clinical trial
1 indication
Indication
Renal AnemiaClinical trial
A Phase 2, Multicenter, Open-label, Randomized, Active-Controlled Study of Efficacy and Safety of AND017 in the Treatment of Anemia in Patients With Chronic Kidney Disease on DialysisStatus: Active (not recruiting), Estimated PCD: 2024-03-01